NEW YORK (GenomeWeb) – Reacting to research published last week in which Chinese scientists conducted germline editing on a non-viable human zygote, the National Institutes of Health today firmly came down in opposition to the use of gene editing technologies in the human germline.

"NIH will not fund any use of gene-editing technologies in human embryos," NIH Director Francis Collins wrote in a statement published on the NIH website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.